Expert Insights On Decentralized Trials
-
Digital Vs. Decentralized Trials: What's The Difference & How Do I Meet Implementation Challenges?
11/18/2021
Digital clinical trials, which have gained momentum since the onset of the pandemic, have the potential to address many of the inefficiencies of traditional trials. This article defines digital clinical trials and how they differ from decentralized clinical trials, as well as how to meet implementation challenges.
-
Is A Decentralized Clinical Trial Right For Your Trial? & 5 Tips For Success
11/11/2021
Pharmaceutical companies have achieved considerable success in decentralizing clinical trials and shown that this model can offer significant benefits — both during the pandemic and afterward. While some elements of decentralization can be applied across all trial types, this article covers several specific trial characteristics that are particularly suited to remote studies, as well as tips to maximize success.
-
How Biopharmas And CROs Can Create Value In Decentralized Global Trials
11/2/2021
The need for biopharma execs to effectively engage CROs in decentralized clinical trials will only increase in the years to come. This article examines the results of a recent Ernst & Young (EY) study and also offers some recommendations for sponsors and CROs to be more effective with decentralized trials.
-
Decentralized Clinical Trials: What Are The Opportunities For Data & Cost Savings?
10/19/2021
Among our industry, sentiment remains positive that decentralized clinical trial models will improve patient centricity and reduce time to market for critical treatments, among other benefits. However, let's take a closer look at this transition to a more decentralized method, focusing in on the opportunities for data and cost savings.
-
Decentralized Clinical Trials: Does Your Strategy Include These Facets?
9/30/2021
Decentralized clinical trials have increased in response to the COVID-19 pandemic, yet this may be due to a convergence of two factors already in play: our reliance on the use of digital health technologies and a move by the FDA and industry toward patient-focused, real-world clinical trials that leverage the technological advances already available.
-
3 Steps To Getting Your First Decentralized Trial Greenlit & Executed
8/17/2021
Decentralized trials are complex, yes, but they are just a different kind of complex. Halloran Consulting unpacks the top three strategies to consider before you begin your decentralized trial design and champion your vision to executives.
-
4 Imperatives For Updating Our Clinical Quality Systems Approach For 2022 Pharma
7/29/2021
The clinical quality management systems approach developed 20 years ago is not sustainable in the today’s industry because we've seen dramatic industry changes in outsourcing, remote monitoring, the use of electronic systems in clinical research, and more. But how do we update our approach for 2022 pharma? This article examines 4 imperatives, including how to accomplish them.
-
3 Easy Ways To Implement Tech & Modernize Your Clinical Trial
6/24/2021
The life sciences industry’s digital transformation has provided the tools to overcome many of the industry’s problems and has unlocked new avenues for the role of tech in clinical trials. Going forward, clinical execs can use tech in a multitude of ways to power clinical trials.
-
Decentralized Trials: Trends & Technology Propelling Home Healthcare Services
6/15/2021
Moving some trial site activities into patients’ homes has been shown to increase recruitment by 60% or more, and it typically maintains patient retention at over 90%. This article delves into research regarding trends and technology enabling decentralized trials.
-
Incorporating The Voices Of Parents And Children In Pediatric Clinical Trials
3/9/2021
Pediatric trials are far more complex than simply evaluating a therapy in the context of a child’s disease or illness. They are a family affair that must accommodate the diverse needs of parents and other family members caring for those children. This article discusses recent survey findings from the Center for Information and Study on Clinical Research Participation.